国新健康 (000503.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 6.56B

MomentumView details →

1D Return

−2.47%

YTD Return

−20.83%

RSI (14)

49.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 6.56B

RSI (14)

49.4

MomentumView details →

1D Return

−2.47%

YTD Return

−20.83%

ProfitabilityView details →

Gross Margin

21.03%

Net Margin

−116.13%

EBITDA Margin

−106.59%

ROE (TTM)

−42.44%

ROA (TTM)

−23.28%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

−2.49%

EPS YoY

—

FCF YoY

−43.29%

Revenue CAGR 3Y

+4.05%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.05

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.43x

Current Ratio

1.96x

Quick Ratio

1.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

+233.34%

Financials snapshotView financials →

Revenue (TTM)

350.50M

Net Income (TTM)

−407.05M

Op. CF (TTM)

−83.09M

Latest newsMore news →

Guoxin Health announced its first-half 2026 results, reporting a net loss of 102 million yuan, wider than the 99.09 million yuan loss in the same period of 2025.11d ago

Similar companies

数字政通300075.SZ 科远智慧002380.SZ 迅游科技300467.SZ 国脉科技002093.SZ 国能日新301162.SZ 达实智能002421.SZ Find similar companies →

Latest newsMore news →

Guoxin Health announced its first-half 2026 results, reporting a net loss of 102 million yuan, wider than the 99.09 million yuan loss in the same period of 2025.11d ago